The World In A Grain Of Sand

The World in a Grain of Sand: Schrödinger

Listen Later

KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Patrick Malone and Mack Healy discuss the biopharma software juggernaut, Schrödinger. We dive into:

  • Schrödinger's biophysics-based drug discovery platform, and the distinction from machine learning approaches
  • A dissection of Schrödinger's software business, as well as co-development partnerships and internal therapeutic programs
  • The story of Schrödinger collaboration with Nimbus on a TYK2 program, resulting in a $4B+ acquisition by Takeda
  • and more

    • For updates from KdT, please subscribe to our Substack.

    Show Notes:

    • Takeda Acquires Nimbus’ Tyk2 Autoimmune Program
    • Discovering Nimbus
    • Selective TYK2 Inhibition: A Story of Vision and Perseverance
      • ...more
      View all episodesView all episodes
      Download on the App Store
      The World In A Grain Of SandBy KdT Ventures
      • 5
      • 5
      • 5
      • 5
      • 5

      5

      19 ratings

      More shows like The World In A Grain Of Sand

      View all
      The Bill Simmons Podcast by The Ringer

      The Bill Simmons Podcast

      30,018 Listeners

      The Long Run with Luke Timmerman by Timmerman Report

      The Long Run with Luke Timmerman

      117 Listeners

      Business Of Biotech by Matt Pillar

      Business Of Biotech

      84 Listeners